Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia
- PMID: 19405135
- DOI: 10.1002/pbc.21992
Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia
Abstract
Background: Despite the extensive literature on neuropsychological sequelae after treatment of childhood acute lymphoblastic leukemia (ALL), the very-long-term neurocognitive outcome of the survivors is poorly studied. We assessed neuropsychological functioning in a population-based cohort of young adult childhood ALL survivors.
Procedure: Neuropsychological testing was performed on 64 survivors an average of 20 years after the diagnosis. The test battery included verbal intelligence quotient (VIQ) and performance intelligence quotient (PIQ), memory function, orientation and attention as well as motor performance. Cranial irradiation had been administered to 44 survivors as part of ALL treatment, whereas 20 survivors had been treated solely with chemotherapy. A control group consisted of 45 healthy young adults. Earlier neuropsychological test results of 45 of the survivors were available for comparison.
Results: The ALL survivors attained significantly lower test scores than the controls in all the neuropsychological function areas. The mean VIQ test scores were 91, 100, and 109 (P < 0.001), and the mean PIQ test scores 100, 111, and 118 (P < 0.001) for the irradiated survivors, non-irradiated survivors and controls, respectively. Memory and motor functions were impaired among the irradiated survivor group compared with the controls. A significant decline in PIQ and VIQ test scores was observed in the irradiated survivor group during the follow-up period, but only in VIQ in the non-irradiated group.
Conclusions: Survivors of childhood ALL suffer from long-lasting progressive neuropsychological impairment, especially when treatment includes cranial irradiation.
(c) 2009 Wiley-Liss, Inc.
Similar articles
-
Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.J Pediatr Hematol Oncol. 2011 Aug;33(6):450-8. doi: 10.1097/MPH.0b013e31820d86f2. J Pediatr Hematol Oncol. 2011. PMID: 21646917
-
P300 abnormalities in long-time survivors of acute lymphoblastic leukemia in childhood--side effects of CNS prophylaxis?Neuropediatrics. 1996 Jun;27(3):130-5. doi: 10.1055/s-2007-973763. Neuropediatrics. 1996. PMID: 8837072
-
A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):561-6. doi: 10.1016/0360-3016(94)00432-K. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852120
-
Neurocognitive sequelae of childhood cancers and their treatment.Pediatr Rehabil. 2004 Jan-Mar;7(1):1-14; discussion 15-6. doi: 10.1080/13638490310001655528. Pediatr Rehabil. 2004. PMID: 14744668 Review. No abstract available.
-
Neurocognitive effects of treatment for childhood cancer.Ment Retard Dev Disabil Res Rev. 2006;12(3):184-91. doi: 10.1002/mrdd.20110. Ment Retard Dev Disabil Res Rev. 2006. PMID: 17061287 Review.
Cited by
-
Frailty in childhood cancer survivors.Cancer. 2015 May 15;121(10):1540-7. doi: 10.1002/cncr.29211. Epub 2014 Dec 19. Cancer. 2015. PMID: 25529481 Free PMC article. Review.
-
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.Support Care Cancer. 2017 Feb;25(2):449-457. doi: 10.1007/s00520-016-3422-9. Epub 2016 Oct 10. Support Care Cancer. 2017. PMID: 27726029 Free PMC article. Clinical Trial.
-
Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.Neurosci Biobehav Rev. 2015 Jun;53:108-20. doi: 10.1016/j.neubiorev.2015.03.016. Epub 2015 Apr 7. Neurosci Biobehav Rev. 2015. PMID: 25857254 Free PMC article.
-
Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.Neuroradiology. 2017 Feb;59(2):147-156. doi: 10.1007/s00234-016-1777-8. Epub 2017 Jan 10. Neuroradiology. 2017. PMID: 28074235 Free PMC article.
-
Longitudinal Trajectories of Neurocognitive Functioning in Childhood Acute Lymphoblastic Leukemia.J Pediatr Psychol. 2021 Feb 19;46(2):168-178. doi: 10.1093/jpepsy/jsaa086. J Pediatr Psychol. 2021. PMID: 33011782 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical